Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hokuriku Seiyaku Co. Ltd.

Division of Abbott Laboratories Inc.
www.hokuriku.co.jp/english/

Latest From Hokuriku Seiyaku Co. Ltd.

Merck/Banyu: A Harbinger of More Western-Japanese Deals?

It's now official: the Japanese drug industry is succumbing to consolidation. The only question is whether the consolidators will be Western companies or the Japanese themselves. The latest and least unexpected transaction: Merck & Co. Inc.'s takeover of the remaining 49% of Banyu Pharmaceutical Co. Ltd. it didn't already own, in a $1.52 billion tender offer.
BioPharmaceutical Japan
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Abbott Laboratories Inc.
  • Senior Management
  • Klaus J Hahn, Head of R&D
    Kunio Iwatani, Pres.
  • Contact Info
  • Hokuriku Seiyaku Co. Ltd.
    Phone: (81) 77988511
    37-1-1, Inokuchi
    Fukui Prefectur
    Katsuyama-city,
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register